Reliability of RSV Antigen Diagnostic Tests in the Presence of Nirsevimab
Nirsevimab did not interfere with RSV detection with any of the antigen tests evaluated, suggesting patients who receive nirsevimab are unlikely to require alternative assays for clinical RSV diagnosis.
Authors
- Carolina Caceres (ORCID: https://orcid.org/0000-0003-2686-765X)
- Kevin M. Tuffy (ORCID: https://orcid.org/0009-0007-8644-5025)
- Deidre Wilkins (ORCID: https://orcid.org/0000-0002-7263-2600)
- Elizabeth J. Kelly (ORCID: https://orcid.org/0000-0002-6988-8576)
- Emma C Schaefer (ORCID: https://orcid.org/0000-0003-3967-1752)
- Sarah R Sincero
- Kelly Ann Mahool
Institutions
- AstraZeneca (Finland) (FI)
- AstraZeneca (Spain) (ES)
Publication Details
- Journal
- The Pediatric Infectious Disease Journal
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1097/inf.0000000000005119
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00